Advertisement
Advertisement

OPRX

OPRX logo

OptimizeRx Corporation Common Stock

6.43
USD
Sponsored
+0.27
+4.37%
Apr 10, 10:56 UTC -4
Open

OPRX Earnings Reports

Positive Surprise Ratio

OPRX beat 29 of 36 last estimates.

81%

Next Report

Date of Next Report
Apr 30, 2026
Estimate for Q1 26 (Revenue/ EPS)
$19.24M
/
$0.02
Implied change from Q4 25 (Revenue/ EPS)
-40.32%
/
-96.08%
Implied change from Q1 25 (Revenue/ EPS)
-12.26%
/
-75.00%

OptimizeRx Corporation Common Stock earnings per share and revenue

On Mar 05, 2026, OPRX reported earnings of 0.51 USD per share (EPS) for Q4 25, beating the estimate of 0.23 USD, resulting in a 120.59% surprise. Revenue reached 32.24 million, compared to an expected 31.72 million, with a 1.63% difference. The market reacted with a -10.49% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 9 analysts forecast an EPS of 0.02 USD, with revenue projected to reach 19.24 million USD, implying an decrease of -96.08% EPS, and decrease of -40.32% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Progress Software Corp (DE)
Report Date
Mar 30, 2026 For Q1 26
Estimate
$1.59
Actual
$1.60
Surprise
+0.03%
logo
Simulations Plus, Inc.
Report Date
Apr 09, 2026 For Q2 26
Estimate
$0.19
Actual
$0.35
Surprise
+75.44%
FAQ
For Q4 2025, OptimizeRx Corporation Common Stock reported EPS of $0.51, beating estimates by 120.59%, and revenue of $32.24M, 1.63% above expectations.
The stock price moved down -10.49%, changed from $7.53 before the earnings release to $6.74 the day after.
The next earning report is scheduled for Apr 30, 2026.
Based on 9 analysts, OptimizeRx Corporation Common Stock is expected to report EPS of $0.02 and revenue of $19.24M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement